Virtuleap

What Virtuleap does

Virtuleap is a Portugal-based healthtech company founded in 2018 that develops virtual reality and AI-powered cognitive training and assessment tools. The company operates two core product lines: Enhance VR, a gamified cognitive training platform delivering short workouts across seven cognitive domains (spatial orientation, problem solving, motor skills, processing, flexibility, memory, and attention) via 15 exercises; and Cogniclear VR, a 14-exercise cognitive assessment tool covering eight cognitive domains that provides examiner-independent scoring. A third product, Volition, applies Cognitive Bias Modification in VR for alcohol use disorder intervention. Technology differentiation is anchored in ecological validity through real-life scenario simulation and the ability to collect ~80,000 behavioral data points per 3-minute session for digital biomarker discovery.

The company generates revenue through three streams: consumer subscription revenue from Enhance VR on the Meta Quest app store, enterprise licensing of Cogniclear VR to healthcare institutions on a quote-based annual subscription model, and funded clinical research partnerships with academic and pharmaceutical institutions. Cogniclear VR achieved Class IIa SaMD classification under EU MDR Rule 11 in 2025, positioning the company toward CE certification. Customer base spans hospital networks (Fortis Healthcare, Penumbra, Vall d'Hebron, Lusíadas Saúde), academic medical centers (UCLA, UCSF, Universitat Internacional de Catalunya), and pharmaceutical companies (Roche).

Virtuleap is headquartered in Lisbon, Portugal, and operates as Virtuleap LDA registered in the United Kingdom. The company employs approximately 20 people and has raised $4.1M in cumulative funding across multiple rounds from 2018-2023. Go-to-market combines enterprise field sales with a self-serve consumer channel and a formal distributor program for regional resellers. Distribution is augmented by OEM integration with Penumbra's Real i-series VR headsets and clinical validation partnerships with leading institutions including UCLA, UCSF/VA, and Vall d'Hebron.

Name

Virtuleap

Legal name

Virtuleap LDA

Website

https://virtuleap.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Virtuleap is a Lisbon-based healthtech company founded in 2018 that develops VR and AI-powered cognitive training (Enhance VR) and assessment (Cogniclear VR) tools, serving healthcare providers, clinical researchers, and consumers across global markets.

Ownership category

akta.pro rank

Product category

Digital Cognitive Therapeutics

NAICS

Other Computer Related Services (541519), Computer Training (611420)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)

akta.pro primary industry

Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)

akta.pro secondary industries

VR/AR/XR Game Studios (MPAFAAAE), VR-Based Skills Training Simulations (Soft Skills, Customer Service, Leadership) (EDAFAJAA)

Keywords

• VR cognitive training
• Cognitive assessment software
• Digital therapeutics
• Brain health technology
• Neuroscience VR platform

Headquarters

HQ city

Lisbon

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Enhance VR Subscriptions: Cognitive training app available via Meta Quest app store, likely operating on subscription or freemium model for individual consumers and possibly enterprise licensing.
2. Cogniclear VR Enterprise Licensing: Cognitive assessment tool offered to healthcare institutions, clinical research organizations, and hospital systems for patient cognitive evaluation and monitoring.
3. Clinical Research Partnerships: Revenue from research collaborations with healthcare institutions, universities, and pharmaceutical companies conducting clinical trials using Virtuleap's VR cognitive tools.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Core offering

Virtuleap develops VR and AI-powered cognitive therapeutics and diagnostics. Its two main products are Enhance VR, a gamified cognitive training app with workouts across seven cognitive domains, and Cogniclear VR, a multidomain cognitive assessment tool with 14 exercises across 8 cognitive domains and examiner-independent scoring. The products serve healthcare institutions, clinical research organizations, and consumers via Meta Quest headsets, with a third product, Volition VR, addressing alcohol use disorder via Cognitive Bias Modification.

Product overview

Virtuleap offers a dual-product portfolio centered on VR-based cognitive solutions: Enhance (cognitive training platform) provides gamified VR workouts across seven cognitive domains, while Cogniclear VR (cognitive assessment tool) delivers examiner-independent multidomain evaluation through 14 immersive exercises. Both products are grounded in neuroscience research and designed for clinical and consumer use, with Enhance targeting cognitive improvement and Cogniclear enabling early detection of cognitive decline.

Differentiator

Problem solved

Functional benefit

Brands

• Enhance: Cognitive therapeutics platform offering short, gamified cognitive workouts across seven categories including memory, attention, processing speed, problem solving, motor skills, flexibility, and spatial orientation.
• Cogniclear VR
• Volition

Products and services

• Enhance VR A cognitive training platform offering gamified VR-based workouts across seven cognitive categories (spatial orientation, memory, attention, flexibility, problem solving, processing, motor control) designed to improve mental agility and support neuroplasticity. Available to consumers via Meta Quest app store and to healthcare enterprises for patient cognitive training.
• Cogniclear VR A multidomain cognitive assessment tool presented in a VR environment with 14 exercises across 8 cognitive categories (problem-solving, attention, cognitive flexibility, temporal location, memory, abstract reasoning, visuoconstructional skills, motor control) that provides examiner-independent evaluation. Designed for healthcare institutions and clinical research organizations for early detection of cognitive impairment.
• Volition VR A VR game inspired by Cognitive Bias Modification (CBM) paradigm designed to address and reduce implicit cognitive biases that influence alcohol-related behaviors by training users to avoid alcohol-related cues and approach healthier imagery. Developed for individuals with Alcohol Use Disorder.

Quantifiable outcome

• Engagement rates: remarkably very low drop-out rates among younger users in ongoing studies
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Ten partnerships are on record, tiered core and flagship.

• Critical CatalystcoreImplementation/ SI/ Consulting Partner · 4 May 2026Partnership to prepare Cogniclear VR, a VR-based cognitive assessment tool, for regulatory compliance under the EU Medical Device Regulation (MDR). Collaboration established comprehensive technical documentation framework and achieved Class IIa SaMD classification under MDR Rule 11, positioning Virtuleap toward CE certification and market entry.
• European CommissionflagshipStrategic or Co-development Partner · 1 October 2024VR Health Champions project, a three-year initiative co-funded by Interregional Innovation Investments (I3) instrument under European Regional Development Fund. Project aims to reduce market barriers for healthcare VR/AR applications. Virtuleap allocated €338,278 in EU funding for regulatory strategy and market-entry preparation for Cogniclear.
• Universitat Internacional de CatalunyacoreStrategic or Co-development Partner · 1 January 2023Partnership to explore Enhance VR's potential for improving emotional regulation in children and adolescents. Study aims to determine if cognitive training can enhance executive functioning leading to better emotional control and reduction in anxiety and depressive symptoms. Funded by Brain & Behavior Research Foundation.
• Lusíadas Saúde / RocheflagshipStrategic or Co-development Partner · 1 January 2023Partnership under Roche's 'Building Tomorrow Together – Innovation in Dementia' initiative to develop Cogniclear VR. Collaboration involves continuous cycles of end-user testing and iterative development to refine the cognitive assessment tool.
• Fortis HealthcareflagshipStrategic or Co-development Partner · 1 January 2023Strategic partnership to deploy Enhance VR and Cogniclear across Fortis Healthcare facilities in India. Collaboration focuses on enhancing patient engagement through interactive cognitive training and assessment, with data-driven insights empowering healthcare professionals.
• Vall d'Hebron Research Institute (VHIR)coreStrategic or Co-development Partner · 1 January 2022VIRCODE project evaluating Enhance VR effectiveness in delaying cognitive decline in individuals with Type 2 diabetes and Mild Cognitive Impairment. Study conducted under direction of Prof. Rafael Simó, funded by LaCaixa Foundation Social Research call.
• UCSF / San Francisco VA Health Care SystemcoreStrategic or Co-development Partner · 1 January 2021Partnership to develop Volition VR, a cognitive bias modification game for individuals with Alcohol Use Disorder. Game trains users to avoid alcohol-related cues and approach healthier imagery to retrain brain's automatic responses.
• PenumbraflagshipOEM/ Whitelabel/ Licensing Partner · 1 January 2021Integration of Enhance VR cognitive training games into Penumbra's Real i-series VR headsets. Partnership broadens reach of innovative cognitive training solutions to care providers and mental health professionals using Penumbra's immersive VR platform.
• UCLAcoreStrategic or Co-development Partner · 1 January 2020Research collaboration using Enhance VR games to study chemotherapy's cognitive impact. Researchers compare results from Virtuleap's cognitive games with traditional neuropsychological tests to evaluate effectiveness of VR-based cognitive assessment.
• VR Health Champions Consortium (18 partners)flagshipStrategic or Co-development PartnerConsortium including Klaster Life Science Krakow, Fondazione Bruno Kessler, Medical University of Lodz, University of Latvia, hospitals such as Unidade Local de Saúde de Coimbra, Medtronic Portugal, Syreon Research Institute, RTE Lab, XR4Europe, coordinated by Instituto Pedro Nunes and co-coordinated by EIT Health InnoStars.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Akili Interactive: Public-now-private digital therapeutics company with FDA-cleared EndeavorRx (video-game-based cognitive therapy for ADHD). Most direct comparable given identical prescription-cognitive-therapeutic + gamified delivery model and overlapping ADHD/MCI indications.
• XRHealth: VR telehealth platform deploying clinician-prescribed VR therapy across physical rehabilitation, cognitive, and mental-health indications in hospital and home settings. Directly comparable VR-software-as-clinical-service model and enterprise healthcare GTM.
• BehaVR: VR-based behavioral health digital therapeutics targeting chronic pain, anxiety, and substance use. Closely comparable VR-immersive-therapeutic delivery, mental-health indication portfolio, and clinical-evidence-led enterprise GTM.
• MindMaze: VR/neuroscience platform for neurorehabilitation and cognitive assessment across stroke, brain injury, and dementia. Direct peer in combining VR with neuroscience-validated cognitive assessment and therapy.
• SyncThink: VR-based eye-tracking cognitive and balance assessment tool (Eyes-Deep) used in concussion management and clinical research. Most directly comparable VR-based cognitive assessment product with FDA pathway and sports-medicine distribution.
• CogniFit: Established cognitive training and assessment platform with scientific validation across memory, attention, and executive function. Comparable in offering both consumer brain training and clinician-oriented cognitive assessment.
• Peak (Brain Training): Consumer-facing cognitive/brain training app developed with Cambridge neuroscientists. Comparable consumer-cognitive-training go-to-market and assessment-style workout model.
• NeuroNation: Evidence-based brain training platform with scientifically-validated cognitive exercises for memory, attention, and reasoning. Comparable consumer plus health-professional positioning with German healthcare-reimbursement relationships.

Broad incumbents

• Click Therapeutics: Prescription digital therapeutics company pursuing FDA pathways for migraine, depression, and other indications. Comparable SaMD-strategy competitor and broader digital-therapeutics peer for enterprise and payer discussions.

Emerging players

• Limbic: AI-driven digital mental health platform used by NHS providers for cognitive behavioral therapy. Adjacent digital-mental-health competitor with overlapping therapeutic AI/data-moa and enterprise clinician GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/virtuleap
• YouTubebit.ly/virtuleapyoutube
• Facebookfacebook.com/virtuleap
• LinkedInlinkedin.com/company/virtuleap
• Instagrambit.ly/virtuleapinstagram

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds8 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virtuleap